Selected article for: "acute lung injury and potential risk"

Author: Wang, Kevin Y; Shah, Pratik; Pierce, Matthew
Title: Convalescent plasma for COVID-19 complicated by ARDS due to TRALI
  • Cord-id: doeifkpv
  • Document date: 2021_1_28
  • ID: doeifkpv
    Snippet: Convalescent plasma, which contains antibodies from recovered individuals, has been used as an effective treatment for infectious diseases in the past and is currently being used as a potential treatment option for COVID-19. Multiple studies have reported this treatment to be safe. We report a case of a patient who developed acute respiratory distress syndrome (ARDS) with features suggestive of transfusion-related acute lung injury after being treated with convalescent plasma for COVID-19. We em
    Document: Convalescent plasma, which contains antibodies from recovered individuals, has been used as an effective treatment for infectious diseases in the past and is currently being used as a potential treatment option for COVID-19. Multiple studies have reported this treatment to be safe. We report a case of a patient who developed acute respiratory distress syndrome (ARDS) with features suggestive of transfusion-related acute lung injury after being treated with convalescent plasma for COVID-19. We emphasise the need to be aware of the potential risk of transfusion reactions and disease worsening with convalescent plasma administration and to weigh the risk and benefits of this therapy before administration to patients and propose that further study be done regarding the potential risks of convalescent plasma.

    Search related documents:
    Co phrase search for related documents
    • active infection and acute lung injury: 1, 2, 3, 4, 5
    • active infection and acute respiratory distress: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • active infection and acute respiratory failure: 1, 2, 3, 4, 5
    • active infection and administration prior: 1, 2
    • active infection and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • active infection patient and acute ards respiratory distress syndrome: 1
    • active infection patient and acute respiratory distress: 1, 2
    • active infection patient and lung injury: 1
    • acute ards respiratory distress syndrome and administration prior: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome develop and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute lung injury and administration prior: 1, 2, 3
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung injury worsening: 1
    • acute respiratory distress and administration prior: 1, 2, 3, 4, 5
    • acute respiratory distress and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress lead and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory failure and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory failure and lung injury worsening: 1